Part B: Quality of Life of the Dialysis Patient

  • J. Ahlmén


Before 1972 the upper age limit for dialysis treatment in USA was 50 years. After this time the medical technology has contributed to an impressive long term patient survival on chronic dialysis. An increasing awareness of the need of the patient to live as close to normal life as possible has led to a concentration on problems concerned with the quality of life (QL). Initial studies to assess QL focused more on physical abilities than the studies with the more multi dimensional QL instruments used today


Life Satisfaction Dialysis Patient Hemodialysis Patient Continuous Ambulatory Peritoneal Dialysis Recombinant Human Erythropoietin 
These keywords were added by machine and not by the authors. This process is experimental and the keywords may be updated as the learning algorithm improves.


Unable to display preview. Download preview PDF.

Unable to display preview. Download preview PDF.


  1. 1.
    Deniston L, Carpentier-Alting P, Kneisley J, Hawthorne V, Port F: Assessment of Quality of life in end-stage renal disease. Health Services Research 24: 555, 1989PubMedGoogle Scholar
  2. 2.
    Ehrlich J, Geerlings W, Jones E, Landais P, Loirat C, Mallick N, Margreiter R, Raine A, Saker L, Salmela K, Selwood N, Tufveson G, Valderrabano F: Report on management of renal failure in Europe. XXIII 9: 6, 1994Google Scholar
  3. 3.
    Grant A, Rodger S, Horwie C, Junor B, Briggs D, MacDougal A: Dialysis at home in the West of Scotland: a comparison of hemodialysis and continuous ambulatory peritoneal dialysis in age and sex-matched controls. Perit Dial Int 12: 365, 1992PubMedGoogle Scholar
  4. 4.
    Evans R, Manninen D, Garrison L, Hunt L, Blagg C, Gutman R, Hull A, Lowrie E: The quality of life of patients with end-stage renal disease. N Eng J Med 312: 553, 1985CrossRefGoogle Scholar
  5. 5.
    Simmons R, Anderson C, Abress L: Quality of life and rehabilitation differences among four end-stage renal disease therapy groups. Scand J Urol Nephrol 24(Suppl 131): 7, 1990Google Scholar
  6. 6.
    Hart G, Evans R: The functional status of ESRD patients as measured by the sickness impact profile. J Chron Dis 40(Suppl 1): 117, 1987Google Scholar
  7. 7.
    Ahlmén J, Carlsson C, Schönborg C: Well-informed patients with end-stage renal disease prefer peritoneal dialysis to hemodialysis. Perit Dial Int 13(Suppl 2): 196, 1993Google Scholar
  8. 8.
    Callender C, Jennings P, Bayton J, Flores J, Tagunicar H, Yeager C, Bond O: Psychologic factors related to dialysis in kidney transplant decisions. Transplant Proc 21:1976, 1989PubMedGoogle Scholar
  9. 9.
    Kjellstrand CM: Age, sex and race inequality in renal transplantation. Arch Intern Med 148: 1305, 1988PubMedGoogle Scholar
  10. 10.
    Voigts A, Felsenfeld A, Llach F: The effects of calciferol and its metabolites on patients with renal failure. II. Calciferol, 1-alfha-hydroxy vitamin D3 and 24,25-dehydroxy vitamin D3. Arch Intern Med 143: 1205, 1983PubMedGoogle Scholar
  11. 11.
    Eschbach J, Egrie J, Downing M, Browne J, Adamson J: Correction of the anemia of end-stage renal disease with recombinant human erytropoietin, results of phase I and II clinical trial. N Eng J Med 316: 73, 1987CrossRefGoogle Scholar
  12. 12.
    Kaye M, Lella J: Discontinuation of dialysis therapy in the demented patient. Am J Nephrol 6: 75, 1986PubMedGoogle Scholar
  13. 13.
    Rothenberg LS: Witholding and withdrawing dialysis from elderly ESRD patients. Part 1. A historical view of the clinical experience. Geriatric Nephrology and Urology 2: 109, 1992PubMedGoogle Scholar
  14. 14.
    Rothenberg L: Withholding and withdrawing dialysis from elderly ESRD patients: Part 2 — ethical and policy issues. Geriatric Nephrology and Urology 3: 23, 1993PubMedGoogle Scholar
  15. 15.
    Mandai T, Ohashi H, Ishii K, Ono M, Kishi K, Hashimoto Y, Minakata T, Tahagi J, Fujita A, Egoh Y, Tsuchiga K, Sacki H, Fakashima S, Asahi T, Mandai K, Adachi K, Maruyama S, Morimoto K: Quality of life in patients with hemodialysis, coronary artery by pass graft (CABG) surgery and mammary cancer. Quality of Life Research 3: 85, 1994Google Scholar
  16. 16.
    Casselith B, Lusk E, Strouse T, Miller D, Brown L, Cross P, Tenaglia A: Psychosocial status in chronic illness. A comparative analysis of six diagnostic groups. N Eng J Med 311:506, 1984CrossRefGoogle Scholar
  17. 17.
    Karnofsky D, Bucherval J: in The Clinical Evaluation of Chemotherapeutic Agents in Cancer, edited by Macleod CM, New York, Colombia University Press, 1949Google Scholar
  18. 18.
    Campell A, Converse P, Rodgers W: The Quality of American Life, New York, Russel Sage Foundation, 1976Google Scholar
  19. 19.
    Cantril H: The Patterns of Human Concerns, New Brunswick, Rutgers University press, 1965Google Scholar
  20. 20.
    Hunt S, McKenna S, and McEwen J: The Nottingham Health Profile: subjective status and medical consultations. Soc Sci Med 15: 221, 1981Google Scholar
  21. 21.
    Hunt S, McKenna S, McEwen J, Buchett E, Williams J, Papp E: A quantitative approach to perceived health status: a validation study. J Epidemiology and Community Health 34: 281, 1980Google Scholar
  22. 22.
    Bergner M, Bobbitt R, Kressel S, Pollard W, Gibson B, Morris J: The Sickness Impact Profile: conceptual formulation and methology for the development of a health status measure. Inf J Health Serv 6: 393, 1978Google Scholar
  23. 23.
    Laupacis A, Canadian Erytropoietin Study Group: Association between recombinant human erytropoietin and quality of life and exercise capacity of patients receiving hemodialysis. Br Med J 300: 573, 1990Google Scholar
  24. 24.
    Wells L, Marwell G: Self-Esteem: Its Conceptualization and Measurements, Beverly Hills, California, Sage Publications Inc, 1976Google Scholar
  25. 25.
    Simmons RG, Klein SD, Simmons RL: Gift of Life. The Effect of Organ Transplantation on Individual Family and Social Dynamics, New Brunswick (USA) and Oxford (UK), Transaction Books, 1987Google Scholar
  26. 26.
    Beck AT, Ward C, Mendelsohn M, Mock J, Erbaugh J: An inventory for measuring depression. Arch Gen Psychiatry 4:561, 1961PubMedGoogle Scholar
  27. 27.
    Spitzer W, Dobson A, Hall J, Cesterman E, Levi J, Shepherd R, Battista R, Catchlove B: Measuring the quality of life of cancer patients: a concise QL-index for use by physicians. J Chron Dis 34: 585, 1981PubMedGoogle Scholar
  28. 28.
    Churchill D, Torrance G, Taylor D, Barnes C, Ludwin D, Shimiza A, Smith E: Measurement of quality of life in end-stage renal disease: the time trade-off approach. Clin Invest Med 10: 14, 1987PubMedGoogle Scholar
  29. 29.
    Hornberger J, Redelmeier D, Petersen J: Variability among methods to assess patients well-being and consequent effect on a cost-effectiveness analysis. J Clin Epidemiol 45: 505, 1992PubMedGoogle Scholar
  30. 30.
    Fukunishi J: Psychosomatic aspects of patients on hemodialysis. 3. Clinical usefulness of alexithymia. Psychother Psychosom 54: 214, 1990PubMedGoogle Scholar
  31. 31.
    Dew M, Simmons R: The advantage of multiple measures of quality of life. Scand J Urol Nephrol 24(Suppl 131): 23, 1990Google Scholar
  32. 32.
    Wolfe R, Port F, Hawthorne W, Guire K: A comparison of survival among dialysis therapies of choice: in center hemodialysis versus continuous ambulatory peritoneal dialysis at home. Am J Kidney Dis 15: 433, 1990PubMedGoogle Scholar
  33. 33.
    Maiorca R, Vonesch EF, Cavalli P, de Vecchi A, Giangrande A, LaGreca G, Scarpioni L, Bragantini L Castelnuovo C, Castiglioni A, Poisette P, Viglino G; A multicenter, selection adjusted comparison of patient and technique survival on CAPD and hemodialysis. Perit Dial Int 11: 118, 1991PubMedGoogle Scholar
  34. 34.
    Wright L: Survival in patients with end-stage renal disease. Am J Kidney Dis 17: 25, 1991PubMedGoogle Scholar
  35. 35.
    Lundin A, Adler A, Feinroth M: Maintenance hemodialysis. Survival beyond the first decade. JAMA 244: 38, 1983Google Scholar
  36. 36.
    Lowrie E, Lew N: Death risk in hemodialysis patients: the predictive value of commonly measured variables and an evaluation of death rate differences between facilities. Am J Kidney Dis 15: 458, 1990PubMedGoogle Scholar
  37. 37.
    Stewart J, Schvanefeldt N, Christensen N, Lauritzen G, Stein D: The effect of computerized dietary analysis, nutrition education on nutrition, knowledge, nutrition status, dietary compliance and quality of life of hemodialysis patients. J Renal Nutrition 3: 177, 1993Google Scholar
  38. 38.
    Gotch F, Yarian S, Keen M: A kinetic survey of US hemodialysis prescriptions. Am J Kidney Dis 15: 511, 1990PubMedGoogle Scholar
  39. 39.
    Acchiardo S, Runyan K, Hattem K, Ryson B, Faller J, Moore L, Jackson M: Impact of KT/V and protein catabolic rate (PCR) on hemodialysis (HD) mortality. (Abstract) JASN 3: 351, 1992Google Scholar
  40. 40.
    Ahmad S, Cole J: Lower morbidity associated with higher KT/V in stable hemodialysis patients. (Abstract) JASN 1: 346, 1990Google Scholar
  41. 41.
    Churchill D, Wallace J, Ludwin D, Beecroft M, Taylor W: A comparison of evaluative indices of quality of life and cognitive function in hemodialysis patients. Controlled Clinical Trials 12: 159, 1991Google Scholar
  42. 42.
    Kutner N, Brogan D, Kutner M: End-stage renal disease treatment modality and patients’ quality of life. Longitudinal assessment. Am J Nephrol 6: 396, 1986PubMedGoogle Scholar
  43. 43.
    Lindsay R, Oreopoulus D, Burton H. Conley J, Wells G, Fenton S: Adaptation to home dialysis: a comparison of continuous ambulatory peritoneal dialysis and hemodialysis, in Continuous Ambulatory Peritoneal Dialysis, edited by Legrain M, Amsterdam, Excerpta Medica, 1980, p 120Google Scholar
  44. 44.
    Mejia G, Zimmerman S: Comparison of CAPD and hemodialysis for diabetics. Perit Dial Bull 5: 7, 1985Google Scholar
  45. 45.
    Burton H, Kline S, Lindsay R, Heidenheim A: The relationship of depression to survival in chronic renal failure. Psychosomatic Medicine 48: 261, 1986PubMedGoogle Scholar
  46. 46.
    Shulman R, Price J, Spinelli J: Bio psychosocial aspects of long term survival on endstage renal failure therapy. Psychological Medicine 19: 945, 1989PubMedGoogle Scholar
  47. 47.
    Gotch F, Sargent J: A mechnistic analysis of the National Cooperative Dialysis study (NCDS). Kidney Int 28: 526, 1985PubMedGoogle Scholar
  48. 48.
    Auer J, Gokal R, Stout J, Hillier V, Kincey J, Simon L, Oliver D: The Oxford-Manchester Study of dialysis patients. Scand J Urol Nephrol 24(Suppl 131): 31, 1991Google Scholar
  49. 49.
    Klein S, Simmons R: The psychosocial impact of chronic kidney disease on children, in Gift of Life, edited by Simons RG, Klein SD, Simmons RL, New Brunswick (USA) and Oxford (UK), Transaction books, 1987, p 89Google Scholar
  50. 50.
    Roscoe J, Smith L, Williams A, Stein M, Morton R, Williamson Balfe J, Arbus G: Medical and social outcome in adolescents with endstage renal failure. Kidney Int 40: 948, 1991PubMedGoogle Scholar
  51. 51.
    Westlie L, Urnen A, Nestrud S, Kjellstrand C: Mortality morbidity and life satisfaction in the very old dialysis patients. Trans Am Soc Artif Intern Organs 30: 21, 1984PubMedGoogle Scholar
  52. 52.
    Loew H: Die Dauerdialysebehandlung in hoheren Lebensalter. Z Gerontol 20: 52, 1987PubMedGoogle Scholar
  53. 53.
    McKevitt P, Jones J, Marion R: The elderly on dialysis: physical and psychosocial functioning. Dialysis and Transplantation 15: 130, 1986Google Scholar
  54. 54.
    Neu S, Kjellstrand C: Stopping long term dialysis: an empirical study of withdrawal of life supporting treatment. N Eng J Med 314: 14, 1986CrossRefGoogle Scholar
  55. 55.
    Roberts J, Kjellstrand C: Choosing Death. Acta Med Scand 223: 181, 1988PubMedCrossRefGoogle Scholar
  56. 56.
    Wehle B, Ahlmén J: Prudent withdrawal of chronic dialysis treatment. Scand J Urol Nephrol 24(Suppl 131): 47, 1990Google Scholar
  57. 57.
    Schnack S, Eigler J, Schiffl H, Gurland H-J, Segerer W: Lebensqualität älterer Patienten unter den Bedingungen der Dauerdialyse. Deutsch Med Wshr 115: 1043, 1990Google Scholar
  58. 58.
    Iordanidis P, Alivanis P, Iakovidis A, Dombros N, Tsagalidis I, Balaskus E, Derveniotis V, Ierodiakonou C, Tourkantonis A: Psychiatric and psychosocial status of elderly patients undergoing dialysis. Perit Dial Int 13(Suppl 2): 192, 1992Google Scholar
  59. 59.
    Morgan B: The relationship between chronological age and perceived quality of life of hemodialysis patients. ANNA J 17:63, 1990PubMedGoogle Scholar
  60. 60.
    Kutner N, Brogan D: Assisted survival aging and rehabilitation needs: comparison of older dialysis patients and age-matched peers. Arch Phys Med Rehabil 73: 309, 1992PubMedGoogle Scholar
  61. 61.
    Jacobson S, Fryd D, Lins LE, Matson M, Sutherland D, Kjellstrand C: Transplantation, hemodialysis and continuous ambulatory peritoneal dialysis for end-stage renal disease in diabetic patients. J Diabet Complications 2: 150, 1988PubMedGoogle Scholar
  62. 62.
    Borgel F, Benhamou P, Zmirou D, Balducci F, Halimi S, Cordonnier D: Assessment of handicap in chronic dialysis diabetic patients (uremidiab § study). Scand J Rehab Med 24: 203, 1992Google Scholar
  63. 63.
    Borgel F, Pasqvier B, Benhamou P, Halimi S: Evaluation du handicap chez le patient diabetique. Ann Readapt Med Phys 33: 81, 1990Google Scholar
  64. 64.
    Julius M, Hawthorne V, Carpentier-Alting P, Kneisley J, Wolfe R, Port F: Independence in activities of daily living for end-stage renal disease patients: biomedical and demographic correlates. Am J Kidney Dis 13: 61, 1989PubMedGoogle Scholar
  65. 65.
    Fukunishi I: Psychosomatic aspects of patients on hemodialysis. Alexithymic trait of hemodialysis patients with diabetic nephropathy. Psychother Psychosom 52:58, 1989PubMedCrossRefGoogle Scholar
  66. 66.
    Hoothay F, De Stefano A, Leary E, Foley-Hartel T: Life Satisfaction and coping of diabetic hemodialysis patients. ANNA J 17:361, 1990PubMedGoogle Scholar
  67. 67.
    Reiss D: Patient, family and staff responses to end-stage renal disease. Am J Kidney Dis 15: 194, 1990PubMedGoogle Scholar
  68. 68.
    Tzamaloukas A, Murphy G, Spalding T: Diabetic nephropathy eleven-year survival on hemodialysis. Clin Nephrol 38: 234, 1992PubMedGoogle Scholar
  69. 69.
    Flynn C: Why blind diabetics with renal failure should be offered treatment. Er Med J 287: 1177, 1983Google Scholar
  70. 70.
    Comty C, Leonard A, Shapiro F: Psychosocial problems in dialyzed diabetic patients. Kidney Int 6(Suppl 1): 144, 1974Google Scholar
  71. 71.
    Wai L, Burton H, Richmond J, Lindsay R: Influence of psychosocial factors on survival of home-dialysis patients. Lancet ii: 155, 1981Google Scholar
  72. 72.
    McClellan W, Anson C, Birkeli K, Tuttle E: Functional status and quality of life: predictors of early mortality among patients entering treatment for end stage renal disease. J Clin Epidemiol 44: 83, 1991PubMedGoogle Scholar
  73. 73.
    King K: Noncompliance in the chronic dialysis population. Dialysis & Transplantation 20: 67, 1991Google Scholar
  74. 74.
    Manley M, Sweeney J: Assessment of compliance in hemodialysis adaptation. J Psychosom Res 30: 153, 1986PubMedGoogle Scholar
  75. 75.
    Kimmel P: Towards a developmental view of end-stage renal disease. Am J Kidney Dis 15: 191, 1990PubMedGoogle Scholar
  76. 76.
    Blodgett C: A selected review of the literature of adjustment to hemodialysis. Int J Psychiatry Med 11: 97, 1981PubMedGoogle Scholar
  77. 77.
    Kaplan De Nour A: Persönlichheitsfaktorer und Adaptation, in Psychonephrologie, edited by Balch FB, Koch U, Speidel H, Berlin, Heidelberg, New York, Tokyo, Springer-Verlag, 1985, p 303 78.Google Scholar
  78. 78.
    Friedlander R, Viedermann M: Children of dialysis patients. Am J Psychiatry 139: 100, 1982PubMedGoogle Scholar
  79. 79.
    Sensky T: Psychosomatic aspects of end-stage renal failure. Psychother Psychosom 59: 56, 1993PubMedGoogle Scholar
  80. 80.
    Chowance G, Binik Y: End stage renal disease and the marital dyad: an empirical investigation, Soc Sci Med 28: 971, 1989Google Scholar
  81. 81.
    Soskolne V, Kaplan De-Nour A: The psychosocial adjustment of patients and spouses to dialysis treatment. Soc Sci Med 29: 497, 1989PubMedGoogle Scholar
  82. 82.
    Kaplan De Nour A: Stresses and reactions of professional hemodialysis staff. Dial Transplant 13: 137, 1984Google Scholar
  83. 83.
    Ferrans C, Powers M: Quality of life index: development and psychometric properties. Advances in Nursing Science 8: 15, 1985PubMedGoogle Scholar
  84. 84.
    Ferrans C, Powers M, Kasch C: Satisfaction with health care of hemodialysis patients. Research in Nursing & Health 10: 367, 1987Google Scholar
  85. 85.
    Larsen D, Rootman I: Physician role performance and patient satisfaction. Soc Sci Med 10: 29, 1976PubMedGoogle Scholar
  86. 86.
    Levy N: Psychological reaction to machine dependency. Psychiatry Clinics of North America 13: 246, 1981Google Scholar
  87. 87.
    Devins G: Illness intrusiveness and quality of life in endstage renal disease: comparison and stability across treatment modalities. Health Psychology 9: 117, 1990PubMedGoogle Scholar
  88. 88.
    Morris P, Jones B: Life satisfaction across treatment methods for patients with end-stage renal failure. Med J Austr 150: 428, 1989Google Scholar
  89. 89.
    Morris P, Jones B: Transplantation versus dialysis: a study of quality of life. Transplant Proc 20: 23, 1988PubMedGoogle Scholar
  90. 90.
    Koch V, Muthny F: Quality of life in patients with end-stage renal disease in relation to the method of treatment. Psychother Psychosom 54: 161, 1990PubMedGoogle Scholar
  91. 91.
    Wolcott D, Nissenson A: Quality of life in chronic dialysis patients: a critical comparison of continuous ambulatory peritoneal dialysis and hemodialysis. Am J Kidney Dis 9: 402, 1988Google Scholar
  92. 92.
    Schlebusch L, Botha G, Bosch B: Coping styles in hemodialysis and continuous peritoneal dialysis patients. Dial Transplant 13: 517, 1984Google Scholar
  93. 93.
    Yanagida E, Streltzer J, Siemsen A: Denial in dialysis patients: relationship to compliance and other variables. Psychosomatic Medicine 43: 271, 1981PubMedGoogle Scholar
  94. 94.
    Theorell T, Konarski-Svensson J, Ahlmén J, Perski A: The role of paid work in Swedish chronic dialysis patients nation — wide survey: paid work and dialysis. J Int Med 230: 501, 1991Google Scholar
  95. 95.
    Wolcott D, Nissenson A, and Landswerk J: Quality of life in chronic dialysis patients. Factors unrelated to dialysis modality. General Hospital Psychiatry 10: 2647, 1988Google Scholar
  96. 96.
    Livesley J: Factors associated with psychiatric symptoms in patients undergoing chronic hemodialysis. Can J Psychiatry 26: 562, 1981PubMedGoogle Scholar
  97. 97.
    Sayag R, Kaplan De-Nour A, Shapira Z, Kahan E, Boner G: Comparison of psychosocial adjustment of male non diabetic kidney transplant and hospital hemodialysis patients. Nephron 54: 214, 1990PubMedGoogle Scholar
  98. 98.
    Parfrey P, Vavasour H, Bullock M, Harnett J, Gault M: Symptoms in end-stage renal disease: dialysis and transplantation. Transplantation Proc 19: 3407, 1987Google Scholar
  99. 99.
    Parfrey P, Vavasour H, Gault M: A prospective study of health status in dialysis and transplant patients. Transplantation Proc 20: 1231, 1988Google Scholar
  100. 100.
    Fox E, Peace K, Neale T, Morrison R, Hatfield P, Mellsop G: Quality of life for patients with end-stage renal failure. Renal Failure 13: 31, 1991PubMedGoogle Scholar
  101. 101.
    Tucker C, Ziller R, Smith W, Mars D, Coons M: Quality of life of patients on in-center hemodialysis versus continuous ambulatory peritoneal dialysis. Perit Dial Int 11: 341, 1991PubMedGoogle Scholar
  102. 102.
    Evans R: Recombinant human erythropoietin and the quality of life of end-stage renal disease patients: a comparative analysis. AmJ Kidney Dis 18(Suppl 1): 62, 1991Google Scholar
  103. 103.
    Julius M, Kneisley J, Carpentier-Alting P, Hawthorne V, Wolfe R, Port F: A comparison of employment rates of patients treated with continuous ambulatory peritoneal dialysis vs in center hemodialysis. Arch Intern Med 149: 839, 1989PubMedGoogle Scholar
  104. 104.
    Procci W: Male sexual functioning and maintenance hemodialysis: a prospective study. Dial Transplant 13: 100, 1984Google Scholar
  105. 105.
    Freeman C, Calsyn D, Sherrard D, Paige A: Psychological assessment of renal dialysis patients using standard psychomatric techniques. J Consulting and Clinical Psychology 48: 537, 1980Google Scholar
  106. 106.
    McMahon L, Dawborn J: Subjective quality of life assessment in hemodialysis patients at different levels of hemoglobin following use of recombinant human erytropoietin. Am J Nephrol 12: 162, 1992PubMedGoogle Scholar
  107. 107.
    Levy N: Sexual adjustment to maintenance hemodialysis and renal transplantation. National survey by questionnaire. Preliminary report. Trans Am Soc Artif Intern Organs 19: 138, 1973PubMedGoogle Scholar
  108. 108.
    Stout J, Auer J, Kincey J, Hillier U, Gokal R, Simon G, Oliver D: Sexual and marital relationships and dialysis — the patients’s viewpoint. Perit Dial Bull 7: 97, 1987Google Scholar
  109. 109.
    Winearls C, Oliver D, Pippard M, Reid C, Downing M, Coles P: Effects of human erytropoietin derived from recombinant DNA on the anemia of patients maintained by chronic hemodialysis. Lancet ii: 1175, 1986Google Scholar
  110. 110.
    Wadhwa N, Friend R, Russo N, Cabralda T, Howell N, and Suh H: Erytropoietin and quality of life in ESRD patients. (Abstract) J Am Soc Nephrol 2: 390, 1991Google Scholar
  111. 111.
    Mayer G, Thum J, Cada E, Stummvoll H, Graf H: Aerobic and anaerobic exercise capacity in patients on chronic hemodialysis and long-term recombinant human erytropoietin therapy. Nephron 51(Suppl 1): 34, 1989PubMedGoogle Scholar
  112. 112.
    McMahon L, Johns J, McKenzie A, Austin M, Fowler R: Hemodynamic changes and physical performance at comparative levels of hemoglobin after long term treatment with recombinant erytopoietin. Nephrol Dial Transplant 7: 1199, 1992PubMedGoogle Scholar
  113. 113.
    Lewis N, Macdougall I, Coles G, Williams J, Fox K, Increased exercise capacity and reversal of exercise induced myocardial ischemia in hemodialysis patients treated with recombinant human erythropoietin. Br Heart J 61:436, 1989Google Scholar
  114. 114.
    Osberg J, Meares G, McKee D, Burnett G: Intellectual functioning in renal failure and chronic dialysis. J Chronic Dis 35: 445, 1982PubMedGoogle Scholar
  115. 115.
    Fennell R, Rasbury W, Fennell E, Morris M: Effects of kidney transplantation on cognitive performance in a pediatric population. Pediatrics 74: 273, 1984PubMedGoogle Scholar
  116. 116.
    Corea A: Case management of the anemic patient: epoetin alfa-focus on cognitive function. ANNA J 20: 350, 1993PubMedGoogle Scholar
  117. 117.
    Nissenson A: Recombinant human erytropoietin: impact on brain and cognitive function, exercise tolerance, sexual potency and quality of life. Semin Nephrol 9(Suppl 2): 25, 1989PubMedGoogle Scholar
  118. 118.
    Smith B, Winslow E, Cognitive changes in chronic renal patients during hemodialysis. ANNA J 17;283, 1990PubMedGoogle Scholar
  119. 119.
    Turner M, Ongkingco R, Hersch S. Moss H, El-Amin D, Ruley E: Effect of r-erythropoietin (Epo) on cognitive function of children with chronic failure. (Abstract) J Am Soc Nephrol 2: 390, 1991Google Scholar
  120. 120.
    Wolcott D, Schweitzer S, Marsh J. Nissenson A: Recombinant erythropoietin improves cognitive function and quality of life (QL) of chronic hemodialysis patients. (Abstract) Kidney Int 33: 242, 1988Google Scholar
  121. 121.
    Wolcott D, Marsch J, La Rue A, Carr C, Nissenson A: Recombinant human erythropoietin treatment may improve quality of life and cognitive function in chronic hemodialysis patients. Am J Kidney Dis 14: 478, 1989PubMedGoogle Scholar
  122. 122.
    Nissenson AR: Cognitive function in dialysis patients: impact of epoietin alfa. New Directions in Anemia 2: 1, 1991Google Scholar
  123. 123.
    Grimm G, Stockenhuber F, Schneweiss B, Madl C, Zeitlhofer J, Schneider B: Improvement of brain function in hemodialysis patients treated with erytropoietin. Kidney Int 38:480, 1990PubMedGoogle Scholar
  124. 124.
    Lundin AP: Quality of life, subjective and objective improvements with recombinant human erythropoietin therapy. Semin Nephrol 9(Suppl 1): 22, 1989PubMedGoogle Scholar
  125. 125.
    Lillevang S, Bangsgaard Pedersen F: The quality of life for hemodialysis patients before and after erythropoietin treatment. A double-blind, randomized placebocontrolled investigation. Ugeskr Laeger 152: 2999, 1990PubMedGoogle Scholar
  126. 126.
    Laupacis A, Wong C, Churchill D and the Canadian erythropoietin study group: The use of generic and specific Quality-of-life measures in hemodialysis patients treated with erytropoietin. Controlled Clinical Trials 12(Suppl): 168S, 1991Google Scholar
  127. 127.
    Delano B: Improvements in quality of life following treatment with r-Hu Epo in anemic hemodialysis patients. Am J Kidney Dis 14(Suppl 2): 14, 1989PubMedGoogle Scholar
  128. 128.
    Foulks C, Cushner H: Sexual dysfunction in the male dialysis patient: pathogenesis, evaluation and therapy. Am J Kidney Dis 8: 211, 1986PubMedGoogle Scholar
  129. 129.
    Bommer J, Kugel M, Schwobel B, Ritz E, Barth H, Seelig R: Improved sexual function during recombinant human erythropoietin therapy. Nephrol Dial Transplant 5: 204, 1990PubMedGoogle Scholar
  130. 130.
    Valderrabano F, Moreno F, Arucil FJ, Principe de Asturias H, and Gregorio Maranon H: A controlled study of the effect of erythropoietin on the quality of life of elderly hemodialysis patients.(Abstract) J Am Soc Nephrol 3: 432, 1992Google Scholar
  131. 131.
    Barany P, Pettersson E, Bergström J: Erytropoietin treatment improves quality of life in hemodialysis patients. Scand J Urol Nephrol 24(Suppl 131): 55, 1990Google Scholar
  132. 132.
    Auer J, Oliver D, Winearls C: The quality of life of dialysis patients treated with recombinant human erythropoietin. Scand J Urol Nephrol 131(Suppl 1): 61, 1990Google Scholar
  133. 133.
    Auer J, Simon G, Stevens J, Griffiths P, Howarth D, Amastassiades E, Gokal R, Oliver D: Quality of life improvements in CAPD-patients treated with subcutaneosly administered erythropoietin for anemia. Peril Dial Int 12: 40, 1992Google Scholar
  134. 134.
    Lazarus M: Update on adverse reactions to erythropoietin therapy. ASAIO J 40: 70, 1994CrossRefGoogle Scholar
  135. 135.
    Brown C, Kierman M, Zhao Z-H, Larsson R, Friedman E: Treatment of azotemic, anemic patients with recombinant human erythropoietin raises whole blood viscosity proportional to hematocrit. (Abstract) Kidney Int 33: 184, 1988Google Scholar
  136. 136.
    Bergrem H, Danielsson B, Eckhardt K-U, Kurtz A, Stridsberg M: A case of antierythropoietin antibodies following recombinant human erythropoietin treatment, in Erythropoietin Molecular Physiology and Clinical Applications, edited by Bauer C, Koch KM, Scigalla P, Wieczorelke L, New York, Marcel Dekker Inc, 1993, p 265Google Scholar
  137. 137.
    Harris L, Luft F, Rudy D, Tierny M: Clinical correlates of functional status in patients with chronic renal insufficiency. Am J Kidney Dis 21: 161, 1993PubMedGoogle Scholar
  138. 138.
    Fries J, Spitz P, Kraines R, Holman R: Measurement of patient outcome in arthritis. Arthritis and Rheumatism 23: 137, 1980PubMedGoogle Scholar
  139. 139.
    Laupacis A, Muirhead N, Keown P, Wong C: A diseasespecific questionnaire for assessing quality of life in patients on hemodialysis. Nephron 60: 302, 1992PubMedGoogle Scholar
  140. 140.
    Parfrey P, Vavasour H, Bullock M, Henry S, Harnett J, Gault M: Development of a health questionaire specific for end-stage renal disease. Nephron 52: 20, 1989PubMedGoogle Scholar
  141. 141.
    Wright S, Stein A, Boyle H, Moorhouse J, Walls J: Health-related quality of life in end-stage renal failure. (Abstract) Quality of Life Research 3: 63, 1994Google Scholar
  142. 142.
    McNair D, Lorr M, Doppleman L: Profile of Mood Status Manual, San Diego, Education and Industrial Testing Service, 1971Google Scholar
  143. 143.
    Bradburn N: The Structure of Psychological Well-Being, Chicago, Aldine Publishing Company, 1969Google Scholar
  144. 144.
    Fazio A: A concurrent valuational study of the NHCS general well-being schedule. Vital and Health Statistics. DHEW publication no (HRA) 78-1347, National Center for Health Statistics, Hyattsville, MD, 1977Google Scholar
  145. 145.
    Ahlmén J: Quality of life: views among patients on active treatment of uremia. Scand J Urol Nephrol 131(Suppl 1): 43, 1990Google Scholar
  146. 146.
    Croog S, Levine S, Testa M: The effects of antihypertensive therapy on the quality of life. N Eng J Med 314: 1657, 1986CrossRefGoogle Scholar
  147. 147.
    Gayatt G, Deyo R, and Charlson M: Responsiveness and validity in health status measurement: a clarification. J Clin Epidem 42: 403, 1989Google Scholar
  148. 148.
    Bergner M: Quality of life, health status and clinical research. Medical Care 27: 148, 1989Google Scholar
  149. 149.
    Mosteller F, Ware J, Levine S: Comments on the conference on Advances in Health Status Assessment. Medical Care 27: 282, 1989Google Scholar
  150. 150.
    Kutner N, Fair P, Kutner M: Assessing depression and anxiety in chronic dialysis patients. J Psychosom Res 29: 23, 1985PubMedGoogle Scholar
  151. 151.
    Lichert R: A technique for the measurements of attitudes. Arch Psychol 1: 140, 1932Google Scholar
  152. 152.
    Scott J, Huskisson E: Graphic representation of pain, Pain 2: 175, 1976PubMedGoogle Scholar

Copyright information

© Kluwer Academic Publishers 1996

Authors and Affiliations

  • J. Ahlmén
    • 1
  1. 1.Department of NephrologyCentral HospitalSkévdeSweden

Personalised recommendations